ArticleRSC medicinal chemistry2024

Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer.

Yuejie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.